02 January 2019 08:15 CET

Karo Intressenter AB höjer erbjudandevederlaget i det kontanta offentliga uppköpserbjudandet till aktieägarna i Karo Pharma Aktiebolag och förlänger acceptfristen

#EQT VIII #Karo Pharma

För mer information, klicka här.

Latest news

09 March 2023
EQT Life Sciences Co-leads $88 Million Series B Financing in QurAlis
03 March 2023
EQT Value-Add Infrastructure to acquire SK Shieldus, a leading South Korean integrated security operator
01 March 2023
EQT Active Core Infrastructure announces first investment to acquire Radius Global Infrastructure
21 February 2023
EQT strengthens its commitment to South Korea – opens new office in Seoul
17 February 2023
EQT Private Equity exceeds minimum acceptance threshold in takeover offer for va-Q-tec